Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xeris Biopharma Holdings, Inc. | 1,777,721 | reported | 12 Mar 2026 | tx 22+1,502,586−310,712 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Mar 2026 | EXERCISE | Xeris Biopharma Holdings, Inc. | 48,894 | 4.09 USD | |
| 12 Mar 2026 | EXERCISE | Xeris Biopharma Holdings, Inc. | 4 | 3.94 USD | |
| 12 Mar 2026 | EXERCISE | Xeris Biopharma Holdings, Inc. | 4 | 3.94 USD | deriv |
| 12 Mar 2026 | EXERCISE | Xeris Biopharma Holdings, Inc. | 48,894 | 4.09 USD | deriv |
| 31 Jan 2026 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 30,289 | 7.36 USD | |
| 31 Jan 2026 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 68,454 | 7.36 USD | |
| 31 Jan 2026 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 27,319 | 7.36 USD | |
| 30 Jan 2026 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 168,463 | 0.00 USD | |
| 30 Jan 2026 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 225,225 | 0.00 USD | deriv |
| 08 Jan 2026 | SALE | Xeris Biopharma Holdings, Inc. | 15,000 | 8.00 USD | |
| 02 Oct 2025 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 733 | 8.31 USD | |
| 11 Sept 2025 | OTHER | Xeris Biopharma Holdings, Inc. | 2,000 | 0.00 USD | |
| 01 Aug 2025 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 14,651 | 5.38 USD | |
| 13 Jun 2025 | PURCHASE | Xeris Biopharma Holdings, Inc. | 25,000 | 4.38 USD | |
| 02 Apr 2025 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 733 | 5.15 USD | |
| 31 Jan 2025 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 48,834 | 3.56 USD | |
| 31 Jan 2025 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 29,300 | 3.56 USD | |
| 31 Jan 2025 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 185,000 | 0.00 USD | |
| 31 Jan 2025 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 500,000 | 0.00 USD | deriv |
| 03 Jan 2025 | TAX_WITHHOLDING | Xeris Biopharma Holdings, Inc. | 24,501 | 3.61 USD | |
| 01 Aug 2024 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 150,000 | 0.00 USD | |
| 01 Aug 2024 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 200,000 | 0.00 USD | deriv |